2023-05-012024-04-302024-04-30false14036981ODP CLINICAL SPECIALIST LTD.2024-10-0486210iso4217:GBPxbrli:pure140369812023-05-01140369812024-04-30140369812023-05-012024-04-30140369812022-04-09140369812023-04-30140369812022-04-092023-04-3014036981bus:SmallEntities2023-05-012024-04-3014036981bus:AuditExempt-NoAccountantsReport2023-05-012024-04-3014036981bus:AbridgedAccounts2023-05-012024-04-3014036981bus:PrivateLimitedCompanyLtd2023-05-012024-04-3014036981core:WithinOneYear2024-04-3014036981core:AfterOneYear2024-04-3014036981core:WithinOneYear2023-04-3014036981core:AfterOneYear2023-04-3014036981core:ShareCapital2024-04-3014036981core:SharePremium2024-04-3014036981core:RevaluationReserve2024-04-3014036981core:OtherReservesSubtotal2024-04-3014036981core:RetainedEarningsAccumulatedLosses2024-04-3014036981core:ShareCapital2023-04-3014036981core:SharePremium2023-04-3014036981core:RevaluationReserve2023-04-3014036981core:OtherReservesSubtotal2023-04-3014036981core:RetainedEarningsAccumulatedLosses2023-04-3014036981core:LandBuildings2024-04-3014036981core:PlantMachinery2024-04-3014036981core:Vehicles2024-04-3014036981core:FurnitureFittings2024-04-3014036981core:OfficeEquipment2024-04-3014036981core:NetGoodwill2024-04-3014036981core:IntangibleAssetsOtherThanGoodwill2024-04-3014036981core:ListedExchangeTraded2024-04-3014036981core:UnlistedNon-exchangeTraded2024-04-3014036981core:LandBuildings2023-04-3014036981core:PlantMachinery2023-04-3014036981core:Vehicles2023-04-3014036981core:FurnitureFittings2023-04-3014036981core:OfficeEquipment2023-04-3014036981core:NetGoodwill2023-04-3014036981core:IntangibleAssetsOtherThanGoodwill2023-04-3014036981core:ListedExchangeTraded2023-04-3014036981core:UnlistedNon-exchangeTraded2023-04-3014036981core:LandBuildings2023-05-012024-04-3014036981core:PlantMachinery2023-05-012024-04-3014036981core:Vehicles2023-05-012024-04-3014036981core:FurnitureFittings2023-05-012024-04-3014036981core:OfficeEquipment2023-05-012024-04-3014036981core:NetGoodwill2023-05-012024-04-3014036981core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3014036981core:ListedExchangeTraded2023-05-012024-04-3014036981core:UnlistedNon-exchangeTraded2023-05-012024-04-3014036981core:MoreThanFiveYears2023-05-012024-04-3014036981core:Non-currentFinancialInstruments2024-04-3014036981core:Non-currentFinancialInstruments2023-04-3014036981dpl:CostSales2023-05-012024-04-3014036981dpl:DistributionCosts2023-05-012024-04-3014036981core:LandBuildings2023-05-012024-04-3014036981core:PlantMachinery2023-05-012024-04-3014036981core:Vehicles2023-05-012024-04-3014036981core:FurnitureFittings2023-05-012024-04-3014036981core:OfficeEquipment2023-05-012024-04-3014036981dpl:AdministrativeExpenses2023-05-012024-04-3014036981core:NetGoodwill2023-05-012024-04-3014036981core:IntangibleAssetsOtherThanGoodwill2023-05-012024-04-3014036981dpl:GroupUndertakings2023-05-012024-04-3014036981dpl:ParticipatingInterests2023-05-012024-04-3014036981dpl:GroupUndertakingscore:ListedExchangeTraded2023-05-012024-04-3014036981core:ListedExchangeTraded2023-05-012024-04-3014036981dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-05-012024-04-3014036981core:UnlistedNon-exchangeTraded2023-05-012024-04-3014036981dpl:CostSales2022-04-092023-04-3014036981dpl:DistributionCosts2022-04-092023-04-3014036981core:LandBuildings2022-04-092023-04-3014036981core:PlantMachinery2022-04-092023-04-3014036981core:Vehicles2022-04-092023-04-3014036981core:FurnitureFittings2022-04-092023-04-3014036981core:OfficeEquipment2022-04-092023-04-3014036981dpl:AdministrativeExpenses2022-04-092023-04-3014036981core:NetGoodwill2022-04-092023-04-3014036981core:IntangibleAssetsOtherThanGoodwill2022-04-092023-04-3014036981dpl:GroupUndertakings2022-04-092023-04-3014036981dpl:ParticipatingInterests2022-04-092023-04-3014036981dpl:GroupUndertakingscore:ListedExchangeTraded2022-04-092023-04-3014036981core:ListedExchangeTraded2022-04-092023-04-3014036981dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-04-092023-04-3014036981core:UnlistedNon-exchangeTraded2022-04-092023-04-3014036981core:NetGoodwill2024-04-3014036981core:IntangibleAssetsOtherThanGoodwill2024-04-3014036981core:LandBuildings2024-04-3014036981core:PlantMachinery2024-04-3014036981core:Vehicles2024-04-3014036981core:FurnitureFittings2024-04-3014036981core:OfficeEquipment2024-04-3014036981core:AfterOneYear2024-04-3014036981core:WithinOneYear2024-04-3014036981core:ListedExchangeTraded2024-04-3014036981core:UnlistedNon-exchangeTraded2024-04-3014036981core:ShareCapital2024-04-3014036981core:SharePremium2024-04-3014036981core:RevaluationReserve2024-04-3014036981core:OtherReservesSubtotal2024-04-3014036981core:RetainedEarningsAccumulatedLosses2024-04-3014036981core:NetGoodwill2023-04-3014036981core:IntangibleAssetsOtherThanGoodwill2023-04-3014036981core:LandBuildings2023-04-3014036981core:PlantMachinery2023-04-3014036981core:Vehicles2023-04-3014036981core:FurnitureFittings2023-04-3014036981core:OfficeEquipment2023-04-3014036981core:AfterOneYear2023-04-3014036981core:WithinOneYear2023-04-3014036981core:ListedExchangeTraded2023-04-3014036981core:UnlistedNon-exchangeTraded2023-04-3014036981core:ShareCapital2023-04-3014036981core:SharePremium2023-04-3014036981core:RevaluationReserve2023-04-3014036981core:OtherReservesSubtotal2023-04-3014036981core:RetainedEarningsAccumulatedLosses2023-04-3014036981core:NetGoodwill2022-04-0914036981core:IntangibleAssetsOtherThanGoodwill2022-04-0914036981core:LandBuildings2022-04-0914036981core:PlantMachinery2022-04-0914036981core:Vehicles2022-04-0914036981core:FurnitureFittings2022-04-0914036981core:OfficeEquipment2022-04-0914036981core:AfterOneYear2022-04-0914036981core:WithinOneYear2022-04-0914036981core:ListedExchangeTraded2022-04-0914036981core:UnlistedNon-exchangeTraded2022-04-0914036981core:ShareCapital2022-04-0914036981core:SharePremium2022-04-0914036981core:RevaluationReserve2022-04-0914036981core:OtherReservesSubtotal2022-04-0914036981core:RetainedEarningsAccumulatedLosses2022-04-0914036981core:AfterOneYear2023-05-012024-04-3014036981core:WithinOneYear2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:CostValuation2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-05-012024-04-3014036981core:Non-currentFinancialInstrumentscore:CostValuation2024-04-3014036981core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-04-3014036981core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-04-3014036981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-04-3014036981core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-04-3014036981core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-04-3014036981core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-04-3014036981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-04-3014036981core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-04-3014036981core:Non-currentFinancialInstrumentscore:CostValuation2023-04-3014036981core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-04-3014036981core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-04-3014036981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-04-3014036981core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-04-3014036981core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-04-3014036981core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-04-3014036981core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-04-3014036981core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-04-3014036981bus:Director12023-05-012024-04-30

ODP CLINICAL SPECIALIST LTD.

Registered Number
14036981
(England and Wales)

Unaudited Financial Statements for the Year ended
30 April 2024

ODP CLINICAL SPECIALIST LTD.
Company Information
for the year from 1 May 2023 to 30 April 2024

Director

ADAM, Ayisha

Registered Address

320 City Road
London
EC1V 2NZ

Registered Number

14036981 (England and Wales)
ODP CLINICAL SPECIALIST LTD.
Balance Sheet as at
30 April 2024

Notes

2024

2023

£

£

£

£

Current assets
Cash at bank and on hand11,383
11,383
Creditors amounts falling due within one year-(16,029)
Net current assets (liabilities)1(14,646)
Total assets less current liabilities1(14,646)
Net assets1(14,646)
Capital and reserves
Called up share capital11
Profit and loss account-(14,647)
Shareholders' funds1(14,646)
The financial statements were approved and authorised for issue by the Director on 4 October 2024, and are signed on its behalf by:
ADAM, Ayisha
Director
Registered Company No. 14036981
ODP CLINICAL SPECIALIST LTD.
Notes to the Financial Statements
for the year ended 30 April 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from sale of goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
2.Average number of employees

20242023
Average number of employees during the year11